Ertapenem Administered Subcutaneously Versus Intravenously

Clinical trial NCT03218800 · TERMINATED

Trial details

NCT number: NCT03218800
Sponsor: Instituto Nacional de Cancer, Brazil
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

Urinary Tract Infections

Start date: 2017-06-01
Primary completion: 2021-02-28
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.